Jay Venkatesan
Director/Board Member chez ELICIO THERAPEUTICS, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Jay R.
Venkatesan is the founder of Tangerine Technologies, Inc. (founded in 1999) and Varro Technologies, Inc. (founded in 1999) where he holds the title of President & Treasurer.
He was also the founder of Ayer Capital Management LP (founded in 2008) and Alpine Biosciences, Inc. (founded in 2015) where he held the title of President & Director.
Additionally, he founded Alpine Bioventures LP (founded in 2015) where he held the title of Managing Partner.
Dr. Venkatesan is also the founder of Zylem Biosciences, Inc. Dr. Venkatesan's current job(s) include being a Director at Elicio Therapeutics, Inc., Transplant Genomics, Inc., Exicure Operating Co., Cell Biotherapy, Inc., Elicio Therapeutics, Inc., Managing Member at Ayer Capital Partners Master Fund LP, and Managing Partner at Alpine Bioventures, GP, LLC.
Dr. Venkatesan's former job(s) include being the President, Chief Executive Officer & Director at Angion Biomedica Corp., Director at Bain Capital Public Equity LP, Director at Targanta Therapeutics Corp., President & Director at Alpine Immune Sciences, Inc., Director at REVA Medical, Inc., Director at Brookside Mezzanine Partners Management LLC, Independent Director at Iovance Biotherapeutics, Inc., Director at Tivorsan Pharmaceuticals, Inc., Independent Director at Alpine Immune Sciences, Inc., Independent Director at Exicure, Inc., Executive Vice President & General Manager at Cascadian Therapeutics LLC, Managing Member at ACM Capital Partners LLC, and Principal at Patricof & Co. Ventures, Inc. Dr. Venkatesan's education history includes an undergraduate degree from Williams College in 1993, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from Perelman School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/11/2023 | 37 266 ( 0,06% ) | 1 M $ | 31/03/2024 |
Postes actifs de Jay Venkatesan
| Sociétés | Poste | Début |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director/Board Member | - |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01/07/2015 |
Cell Biotherapy, Inc.
 Cell Biotherapy, Inc. BiotechnologyHealth Technology Cell Biotherapy, Inc. develops bio therapeutics. The American company was founded by Michael E. Meyers and he has been the CEO since incorporation. | Director/Board Member | - |
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA. | Director/Board Member | - |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Director/Board Member | 01/03/2014 |
| Ayer Capital Partners Master Fund LP | Corporate Officer/Principal | - |
Varro Technologies, Inc.
 Varro Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Varro Technologies, Inc. develops distributed knowledge management applications for the life science industry. It offers a patent-pending technology solution for accessing, managing, and sharing the genetic information. The company was founded by Jay Venkatesan, David Sullivan Shin, Wesley Chan, and Chester M Hedgepeth III on December 22, 2000 and is headquartered in Philadelphia, PA. | Founder | 01/01/1999 |
| Zylem Biosciences, Inc. | Founder | - |
Anciens postes connus de Jay Venkatesan
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jay Venkatesan
| Williams College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Perelman School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| EXICURE, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 23 |
|---|---|
Bain Capital Public Equity LP
 Bain Capital Public Equity LP Investment ManagersFinance Bain Capital Public Equity LP is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1996 as Brookside Capital LP. They are wholly-owned by Bain Capital LP, itself a subsidiary of Bain Capital Holdings LP. Bain Capital Public Equity provides investment advisory services to pooled investment vehicles (Public Equity Funds). Investors in the Public Equity Funds includes high net-worth individuals, banks, thrift institutions, pension and profit sharing plans, trusts, estates, charitable organizations, university endowments, corporations, limited partnerships and limited liability companies or other business entities. | Finance |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
ACM Capital Partners LLC
 ACM Capital Partners LLC Investment ManagersFinance ACM Capital Partners LLC provides investments services. The company is headquartered in Miami, FL. | Finance |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
Transplant Genomics, Inc.
Transplant Genomics, Inc. BiotechnologyHealth Technology Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA. | Health Technology |
Alpine Immune Sciences, Inc. /Old/
 Alpine Immune Sciences, Inc. /Old/ BiotechnologyHealth Technology Alpine Immune Sciences, Inc. operates as a biotechnology company which develops cancer immunotherapy systems. The firm provides immunotherapy and immune synapse solutions. The company was founded by Ryan Swanson and Michael Kornacker in 2015 and is headquartered in Seattle, WA. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
REVA Medical, Inc.
 REVA Medical, Inc. Medical SpecialtiesHealth Technology REVA Medical, Inc. engages in the development and commercialization of medical devices. It focuses on polymer-based bioresorbable products for vascular applications. The company was founded by Robert Bernard Stockman on June 3, 1998 and is headquartered in San Diego, CA. | Health Technology |
Brookside Mezzanine Partners Management LLC
 Brookside Mezzanine Partners Management LLC Investment ManagersFinance Brookside Mezzanine Partners Management LLC (Brookside Capital Partners) is a private equity firm founded in 1977 by John N Irwin and David D Buttolph. The firm is headquartered in Stamford, Connecticut. | Finance |
| Patricof & Co. Ventures, Inc. | Finance |
Varro Technologies, Inc.
Varro Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Varro Technologies, Inc. develops distributed knowledge management applications for the life science industry. It offers a patent-pending technology solution for accessing, managing, and sharing the genetic information. The company was founded by Jay Venkatesan, David Sullivan Shin, Wesley Chan, and Chester M Hedgepeth III on December 22, 2000 and is headquartered in Philadelphia, PA. | Commercial Services |
Tangerine Technologies, Inc.
 Tangerine Technologies, Inc. Packaged SoftwareTechnology Services Tangerine Technologies, Inc. provides software development and business process outsourcing solutions. The company was founded by Jay Venkatesan and Todd Riley Johnson in 1999 and is headquartered in Santa Clara, CA. | Technology Services |
Ayer Capital Management LP
 Ayer Capital Management LP Investment ManagersFinance Founded in 2008 by Jay Venkatesan, Ayer Capital Management LP is a hedge fund manager located in San Francisco. | Finance |
| Ayer Capital Partners Master Fund LP | Miscellaneous |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
Alpine Biosciences, Inc.
 Alpine Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alpine Biosciences, Inc. provided research and development of protocells for treatment of rare diseases and cancer. The company was headquartered in Seattle, WA. | Commercial Services |
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Finance |
Alpine Bioventures LP
 Alpine Bioventures LP Investment ManagersFinance Alpine Bioventures LP invests in companies located in the United States. The fund targets companies operating in the fields of science and healthcare services. It provides financing for seed and early stage capital requirements. It also makes co-investments. | Finance |
Cell Biotherapy, Inc.
Cell Biotherapy, Inc. BiotechnologyHealth Technology Cell Biotherapy, Inc. develops bio therapeutics. The American company was founded by Michael E. Meyers and he has been the CEO since incorporation. | Health Technology |
| Zylem Biosciences, Inc. | Health Technology |
Tivorsan Pharmaceuticals, Inc.
 Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI. | Health Technology |
